Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dexcom Inc shares valued at $53,934 were sold by Malady Kyle on Sep 05 ’25. At $80.86 per share, Malady Kyle sold 667 shares. The insider’s holdings dropped to 22,667 shares worth approximately $1.32 million following the completion of this transaction.
Also, Stern Sadie sold 1,466 shares, netting a total of over 117,280 in proceeds. Following the sale of shares at $80.00 each, the insider now holds 105,223 shares.
Before that, Malady Kyle had added 667 shares to its account. In a trade valued at $53,934, the Director bought Dexcom Inc shares for $80.86 each.
Analysts at Oppenheimer downgraded the stock from ‘”an Outperform”‘ to ‘”a Perform”‘ outlook in a report released in early September. As of August 21, 2025, Argus has initiated its “Buy” rating for DXCM. Earlier on June 16, 2025, Truist initiated its rating. Their recommendation was “a Buy” for DXCM stock.
Analyzing DXCM Stock Performance
On last trading session, Dexcom Inc [NASDAQ: DXCM] plunged -2.13% to $58.02. The stock’s lowest price that day was $56.89, but it reached a high of $60.0 in the same session. During the last five days, there has been a drop of approximately -14.93%. Over the course of the year, Dexcom Inc shares have dropped approximately -16.76%. Shares of the company reached a 52-week high of $93.25 on 02/18/25 and a 52-week low of $56.44 on 10/31/25.
Support And Resistance Levels for Dexcom Inc (DXCM)
According to the 24-hour chart, there is a support level at 56.61, which, if violated, would cause prices to drop to 55.19. In the upper region, resistance lies at 59.72. The next price resistance is at 61.41. RSI (Relative Strength Index) is 29.98 on the 14-day chart, showing oversold technical sentiment.
Is Dexcom Inc subject to short interest?
Stocks of Dexcom Inc saw a sharp steep in short interest on 2025-10-15 dropping by -1.52 million shares to 11.62 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 13.14 million shares. A decline of -13.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.84 of the overall float, the days-to-cover ratio (short ratio) decline to 1.84.
Which companies own the most shares of Dexcom Inc (DXCM)?
In terms of Dexcom Inc share price expectations, FactSet research, analysts set an average price target of 84.5 in the next 12 months, up nearly 42.54% from the previous closing price of $59.28. Analysts anticipate Dexcom Inc stock to reach 99 by 2025, with the lowest price target being 75. In spite of this, 12 analysts ranked Dexcom Inc stock as Buy at the end of 2025. On May 30, 2025, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $104.
